StreetSpread
Live Tracker
Get the App
StreetSpread
·
Technology
· Kalshi
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
Technology
Closes July 1, 2027
Kalshi
Kalshi's current ask is 84¢ for YES on this contract (84% implied). Closes July 1, 2027 (~228 days).
Live price
Side
Cents
Implied
Volume
Kalshi (yes ask)
84¢
84%
$9K
Kalshi (yes bid)
82¢
82%
—
Trade on Kalshi →
Don't just watch the number
Today's top 5 gaps →
The five most actionable spreads across every venue right now — free.
Ask Ace about this market →
3 free questions with the AI analyst — in the app.
Track it live →
Real-time spreads, price history, and alerts on your phone.
Get the app →
Live on the App Store — every venue priced side by side, in your pocket.
Related markets
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027?
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA?
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
StreetSpread aggregates real-time odds across Kalshi, Polymarket, DraftKings, FanDuel, BetMGM, Caesars, and Fanatics. Prices refresh about every two minutes.
Back to live tracker
·
Get the app
.
Follow us:
X (@thestreetspread)
·
Instagram (@thestreetspread)
·
LinkedIn